Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Bioorg Med Chem Lett. 2015 Apr 28;25(12):2501–2504. doi: 10.1016/j.bmcl.2015.04.069

A fluorescent bisboronic acid compound that selectively labels cells expressing oligosaccharide Lewis X

Xingming Gao a, Mengyuan Zhu a, Haiying Fan b, Wenqian Yang a, Weijuan Ni a, Vishnu V R Karnati a, Shouhai Gao a, John Carson b, Brent Weston b,*, Binghe Wang a,*
PMCID: PMC4444404  NIHMSID: NIHMS686060  PMID: 25956415

Abstract

Two fluorescent diboronic acid compounds (6a and 6b) with a dipeptide linker were synthesized as potential sensors for cell surface saccharide Lewis X (LeX). Compound 6a with a dipeptide (H-Asp-Ala-) as the linker was found to selectively label CHOFUT4 cells, which express Lex, at micromolar concentrations, while non-Lex-expressing control cells were not labeled.

Keywords: Biomarker, Boronolectin, Optical imaging

Graphical Abstract

graphic file with name nihms686060f7.jpg


The cell surface carbohydrates of Lewis blood group antigens, Lewis X (Lex), Lewis Y (Ley), Lewis A (Lea), Lewis B (Leb), and their sialylated derivatives (e.g. sialy Lewis X (sLex)) that contain the fucose moiety play important roles in various types of biochemical recognition processes. These cell surface carbohydrates have also been associated with the development and progression of many types of cancers.14

The Lex structure (Figure 1), a trisaacharide Galβ(1–4)[Fucα(1–3)]GlcNAcβ-1, is present in a variety of normal and malignant human tissues.5 While the precise physiological role of Lex is still unknown, some insight has been gained regarding its biological activity. It has been shown that the expresion of the Lex antigen varies greatly during the maturation of normal human cell.6 Therefore, Lex is believed to play a role in normal cell development and differentiation.7 The Lex antigen is also presumably associated with the growth of malignant cells because many human cancer tissues accumulate this antigen.8 Furthermore, Lex determinant may function as a recognition structure for endogenous receptors and adhesion molecules such as lectins that are a class of proteins of non-immune origin and bind carbohydrates specifically and noncovalently.9 Additionally, it was suggested that Lex may be related to learning dysfunction in some patients with mental retardation.10 Finally, there is evidence that the Lex determinant may play a role in inflammatory responses.11 Since the Lex determinant is believed to be very pathologically important, the development of compounds (sensors) that selectively recognize Lex could help the diagnosis and early detection of various diseases. Such compounds could also aid in interpreting the binding of Lex with different receptors and therefore aid in the development drugs that act as inhibitors of the binding and activity of Lex.

Figure 1.

Figure 1

The structures of Lewis X (Lex) trisaccharide.

Boronic acids have been known for decades to bind saccharides via reversible covalent interactions.1214 The most common interactions are with linear diols, cis-1,2-diols on five-membered rings, or 1,3-diols to form five- or six-membered rings, respectively. Therefore, carbohydrate sensing work during the last decade has been focused on using boronic acid as the basic recognition moiety.1517 Our laboratory has been particularly interested in the development of fluorescent sensors for biologically important carbohydrates.1821 For the construction of fluorescent sensors for cell surface carbohydrates, we envision that bisboronic acid compounds with a proper spatial arrangement of the two boronic acid moieties, which are complementary to the multiple pairs of diols, have the potential for selective recognition of the target carbohydrate. In doing so, we have selected Shinkai’s anthracene-based fluorescent boronic acid as the binding and reporting unit22 and have sampled a series of linkers with different length, rigidity, and spatial orientation in search of an optimal arrangement of the two boronic acid units. In our previous work, we reported a boronic acid-based fluorescent sensor that could selectively label sLex.1820 The same sensor was found to be useful in mass spectrometric imaging work for cancer tissues.21 Herein, we report a fluorescent boronic acid compound (6a) that selectively label Lex, which was derived from screening a large number of analogs with a range of boron-boron distance considered as appropriate for recognition of Lex. The computational aspect of this study is addressed later.

Compounds 6a and 6b contain the dipeptides H-Asp-Ala and H-Glu-Ala, respectively, as dicarboxylic acid linkers. The synthesis of these two compounds is shown in Scheme 1. The anthracence-based amine 1 was prepared by following a procedure reported previously.19 Compounds 3a and 3b were obtained through a coupling reaction of the anthracence-based amine 1 with Fmoc protected dipeptide acids 2a and 2b, respectively.19 After Boc deprotection of compound 3 (3a and 3b) with trifuoroacetic acid (TFA), the unprotected free amines were then reacted with boronate 4 in the presence of potassium carbonate to give the diboronic acid compound 5 (5a and 5b).20 The final product 6 (6a and 6b) was obtained through deprotection of the Fmoc group with diethylamine in CH2Cl2.21

Scheme 1.

Scheme 1

Synthesis of boronic acid compounds 6a and 6b: i) 2a or 2b, EDCI, HOBt, DIEA, CH2Cl2; ii) TFA/ CH2Cl2 (1:2, v/v); iii) 4, K2CO3, CH3CN; iv) (CH3CH2)2NH/ CH2Cl2 (1:1, v/v).

Flow cytometry analysis of hepatocellular carcinoma (HCC) lines with anti-carbohydrate monoclonal antibodies was performed to characterize surface glycan expression. Cell lines were prepared and stained with monoclonal anti-carbohydrate antibodies at saturating concentrations as described.23,24 Cells were analyzed on a Becton-Dickinson FACS as previously described.24 The results indicated that CHOFUT4 expresses Lex only; Chinese hamster ovary (CHO) cell line does not express any glycans; HEP3B predominantly express Ley; B16FUT3 expresses sialyl Lewis a (sLea) only; COLO205 expresses sLex and sLea, but not Lex.

Compounds 6a and 6b were examined for their ability to label cells that express different carbohydrates. The fluorescent labeling studies were carried out in a cell culture system using these cells following previous described procedures.19 The plates containing the labeled cells were examined with phase contrast microscopy followed by fluorescent microscopy (blue cube wavelengths 370 nm excitation, 426 nm emission; 20 × lens). Plates were photographed and images were captured with the Nikon ACT-1 program (v 2.10). The phase contrast and fluorescent images were then overlaid, organized and labeled using Adobe Photoshop. The fluorescence intensity is displayed with mean gray value: black represents low signal intensity and white represents high signal intensity. The units (mean gray value) were subtracted from background, where there are no cells. The fluorescent signal was stable for at least 96 h when cells were maintained in darkness.

Figure 2 shows the mean gray value of different cells after incubation with fluorescent boronic acid compound 6a. As discussed above, larger mean gray values mean stronger fluorescence intensity. It is well known that the fluorescence intensity of boronic acid compounds such as 6a would increase after binding with a sugar. It is clear from Figure 2 that CHO that does not express the target carbohydrates shows almost no fluorescence; HEP3B, B16FUT3 and COLO205 that express Ley, sLea, and sLex (and sLea), respectively, show weak fluorescence; CHOFUT4 that express Lex shows the highest fluorescence. These results indicated that compound 6a recognize Lex with selectivity over Ley, sLex, and sLea.

Figure 2.

Figure 2

Densitometry quantification of fluorescent intensity of cells upon incubation with compound 6a. Cells were incubated with 2, 4, and 8 µM of 6a for 30 min. Mean gray values (y-axis) were determined after subtraction of cell-free background. CHOFUT4: Lex only; CHO: none of the glycans; HEP3B: predominantly Ley; B16FUT3: sLea only; COLO205: sLex and sLea, no Lex.

Figure 3 shows representative images of cell-labeling studies. Compared with the control cell CHO that does not express any glycans, the fluorescence of CHOFUT4 that express only Lex increased significantly after incubatation with compound 6a. Compound 6a selectively stained CHOFUT4 at the concentrations of both 2 and 8 µM. Furthermore, compound 6a only slightly stained HEP3B, B16FUT3, and COLO205 that expresses other carbohydrates such as Ley, sLex, and sLea (Figure 4).

Figure 3.

Figure 3

Representative fluorescent labeling studies of compound 6a for CHOFUT4 and CHO cells. A: 6a at 2 µM for CHO; B: 6a at 2 µM for CHOFUT4. C: 6a at 8 µM for CHO; D: 6a at 8 µM for CHOFUT4. λex = 370 nm, λem = 426 nm.

Figure 4.

Figure 4

Selectivity labeling studies of compound 6a. A: CHO (negative control) at 4 uM; B: CHO at 8 uM; C: CHO-FUT4 (Lex-expressing) at 4 uM; D: CHO-FUT4 at 8 uM; E: COLO205 (sLex and Slea; no Lex) at 4 uM; F: COLO205 at 8 uM. The bar graph is the same data in pixels.

The labeling of these cells using compound 6b was also studied. The results indicated that compound 6b did not show significant labeling of these antigens (data not shown). Compound 6a and 6b have a very similar molecular structure. The only structural difference between 6a and 6b is in their linker: compound 6a has H-Asp-Ala as the linker, but 6b has H-Glu-Ala as the linker. These results suggest that a small structural change can significantly affect the ability of a sensor to bind a specific carbohydrate.

In order to understand the conformational features of compounds 6a and 6b that contribute to binding, we performed molecular dynamics simulations of compound 6a,b and Lex in an explicit water model with Desmond3.6.25 As can be seen from Figure 5, the distance between the two boron atoms in compound 6a settled quickly to 5 Å in only 1 ns and stayed there for the duration of the entire simulation process (20 ns). However, the distance between the two boron atoms in compound 6b took quite a long time (5 ns) to reach 5 Å, which is similar to the boron distance in compound 6a. Furthermore, this distance fluctuated in 6b, but not in 6a. These boron atoms even went away from each other for the last 2 ns of simulation in 6b. The results suggested that 6a was able to maintain a stable conformaiton, which is probably favorable for binding. On the other hand, 6b was not able to stay in a conformation favorable for binding. However, because we have no structural evidence to indicate which way the boronic acids might bind with LeX. Therefore, no further computational work was conducted. Thus the computational work only gives hints as to why 6a exibits selectivity.

Figure 5.

Figure 5

Boron distances of compound 6a and compound 6b.

In conclusion, a fluorescent bisboronic acid compound 6a with a dipeptide linker has been developed to target Lex. Compound 6a was found to stain CHOFUT4 cells expressing Lex at micromolar concentrations. To the best of our knowledge, this is the first such synthetic receptor that has been found to fluorescently and selectively label cell expressing Lex.

Acknowledgement

Financial support from the National Institutes of Health (CA88343 and NO1-CO-27184), the Georgia Cancer Coalition through a Distinguished Cancer Scientist Award, and the Georgia Research Alliance through an Eminent Scholar endowment is gratefully acknowledged.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and notes

  • 1.Rho J, Mead JR, Wright WS, Brenner DE, Stave JW, Gildersleeve JC, Lampe PD. J. Proteomics. 2014;96:291. doi: 10.1016/j.jprot.2013.10.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE, Burchell JM. Cancer Res. 2011;71:7683. doi: 10.1158/0008-5472.CAN-11-1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lee B, Arun B, Cohen E, Tin S, Gutierrez-Barrera A, Miura T, Kiyokawa I, Alvarez R, Valero V, Ueno N. Cancer Res. 2012;72 [Google Scholar]
  • 4.Koh YW, Lee HJ, Ahn JH, Lee JW, Gong G. Am. J. Clin. Pathol. 2013;139:746. doi: 10.1309/AJCP2E6QNDIDPTTC. [DOI] [PubMed] [Google Scholar]
  • 5.Fox N, Damjanov I, Knowles BB, Solter D. Cancer Res. 1983;43:669. [PubMed] [Google Scholar]
  • 6.Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E, Hakomori S. Cancer Res. 1984;44:5279. [PubMed] [Google Scholar]
  • 7.Hakomori S, Nudelman E, Levery S, Solter D, Knowles BB. Biochem. Biophys. Res. Commun. 1981;100:1578. doi: 10.1016/0006-291x(81)90699-9. [DOI] [PubMed] [Google Scholar]
  • 8.Hakomori S, Nudelman E, Levery SB, Kannagi R. J. Biol. Chem. 1984;259:4672. [PubMed] [Google Scholar]
  • 9.Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans MJ. Nature. 1981;292:156. doi: 10.1038/292156a0. [DOI] [PubMed] [Google Scholar]
  • 10.Masuda Y, Ohnuma S, Shimizu T, Hishikawa Y. Biol. Psychiat. 1997;42:68. doi: 10.1016/S0006-3223(96)00303-4. [DOI] [PubMed] [Google Scholar]
  • 11.Bevilacqua MP, Stengelin S, Gimbrone MA, Jr, Seed B. Science. 1989;243:1160. doi: 10.1126/science.2466335. [DOI] [PubMed] [Google Scholar]
  • 12.Springsteen G, Wang B. Tetrahedron. 2002;58:5291. [Google Scholar]
  • 13.Nishiyabu R, Kubo Y, James TD, Fossey JS. Chem. Commun. 2012;47:1106. doi: 10.1039/c0cc02920c. [DOI] [PubMed] [Google Scholar]
  • 14.Bull SD, Davidson MG, Van den Elsen JM, Fossey JS, Jenkins ATA, Jiang Y-B, Kubo Y, Marken F, Sakurai K, Zhao J. Acc. Chem. Res. 2012;46:312. doi: 10.1021/ar300130w. [DOI] [PubMed] [Google Scholar]
  • 15.Wang W, Gao X, Wang B. Curr. Org. Chem. 2002;6:1285. [Google Scholar]
  • 16.Hartley JH, James TD, Ward CJ. J. Chem. Soc., Perkin Trans. 2000;1:3155. [Google Scholar]
  • 17.Jin S, Cheng Y, Reid S, Li M, Wang B. Med. Res. Rev. 2010;30:171. doi: 10.1002/med.20155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yang W, Gao S, Gao X, Karnati VV, Ni W, Wang B, Hooks WB, Carson J, Weston B. Bioorg. Med. Chem. Lett. 2002;12:2175. doi: 10.1016/s0960-894x(02)00339-6. [DOI] [PubMed] [Google Scholar]
  • 19.Yang W, Fan H, Gao X, Gao S, Karnati VV, Ni W, Hooks WB, Carson J, Weston B, Wang B. Chem. Biol. 2004;11:439. doi: 10.1016/j.chembiol.2004.03.021. [DOI] [PubMed] [Google Scholar]
  • 20.Chu Y, Wang D, Wang K, Liu ZL, Weston B, Wang B. Bioorg. Med. Chem. Lett. 2013;23:6307. doi: 10.1016/j.bmcl.2013.09.063. [DOI] [PubMed] [Google Scholar]
  • 21.Dai C, Cazares LH, Wang L, Chu Y, Wang SL, Troyer DA, Semmes OJ, Drake RR, Wang B. Chem. Commun. 2011;47:10338. doi: 10.1039/c1cc11814e. [DOI] [PubMed] [Google Scholar]
  • 22.James TD, Sandanayake KRAS, Iguchi R, Shinkai S. J. Am. Chem. Soc. 1995;117:8982. [Google Scholar]
  • 23.Nakaya R, Kohgo Y, Mogi Y, Nakajima M, Kato J, Niitsu Y. J. Gastroenterol. 1994;29:24. doi: 10.1007/BF01229069. [DOI] [PubMed] [Google Scholar]
  • 24.Brinkman-Van der Linden EC, Mollicone R, Oriol R, Larson G, Van den Eijnden DH, Van Dijk W. J. Biol. Chem. 1996;271:14492. doi: 10.1074/jbc.271.24.14492. [DOI] [PubMed] [Google Scholar]
  • 25.Kevin J, Bowers ECHXRODMPEBAGJLKIKMAMFDSJ, David ES. Proceedings of the ACM/IEEE Conference on Supercom; 2006. [Google Scholar]

RESOURCES